Jane Buchan - Aug 11, 2023 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
Director
Signature
/s/ Ilya Rachman as Attorney-In-Fact for Jane Buchan
Stock symbol
IMMX
Transactions as of
Aug 11, 2023
Transactions value $
$0
Form type
4
Date filed
8/14/2023, 04:15 PM
Previous filing
Jun 30, 2023
Next filing
Sep 11, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Stock Options Award $0 +20K $0.00 20K Aug 11, 2023 Common Stock 20K $1.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest monthly over 12 months from the date of grant.